Factor VII activation and oral contraceptives.
Plu-Bureau
G
G
INSERM U258, Cardiovascular Epidemiology Unit, Hôpital Broussais, Paris, France.
Scarabin
P Y
PY
Bara
L
L
Malmejac
A
A
Guize
L
L
Samama
M
M
D000328:Adult; D000941:Antigens / Q000032:analysis; D001794:Blood Pressure; D015992:Body Mass Index; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects / Q000494:pharmacology*; D004789:Enzyme Activation / Q000187:drug effects; D005167:Factor VII / Q000032:analysis / Q000378:metabolism*; D015942:Factor VIIa / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood; D013923:Thromboembolism / Q000097:blood / Q000139:chemically induced*
D000941:Antigens; D003277:Contraceptives, Oral, Combined; D008055:Lipids; C042580:factor VII clotting antigen; D005167:Factor VII; D015942:Factor VIIa